Pfizer Lobbies China's IP Office To Restore Viagra Patent
Pfizer Inc. has quietly been lobbying China's State Intellectual Property Office to restore the company's domestic-use patent for the erectile-dysfunction drug Viagra, according to a published report....To view the full article, register now.
Already a subscriber? Click here to view full article